1 / 18

Parkinson’s Disease

Parkinson’s Disease. By Nik Sanyal. This = movement disorder caused by degeneration of dopamine pathways in substantia nigra Characterised by : TREMOR RIGIDITY BRADYKINESIA +/- postural instability. Epidemiology + Risk Factors. Peak age of onset = 55-65 Men > Women

virote
Télécharger la présentation

Parkinson’s Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Parkinson’s Disease By Nik Sanyal

  2. This = movement disorder caused by degeneration of dopamine pathways in substantia nigra • Characterised by: • TREMOR • RIGIDITY • BRADYKINESIA • +/- postural instability

  3. Epidemiology + Risk Factors • Peak age of onset = 55-65 • Men > Women • 2nd most common neurodegenerative disease after Alzheimer’s • Risk factors: • Age • Gender • Spring birth • Exposure to pesticides e.g. paraquat or Agent Orange

  4. Pathogenesis • Most cases = idiopathic PD. Leading to a progressive degeneration + development of Lewy bodies in substantianigra. • Other pathways – mesocortical, mesolimbic + tubero-hypophyseal • Genetics (lead to early onset): • mutations in c’some 6 = AR PD • Alpha synuclein mutation • Parkin gene Dopamine has a role in disinhibition of motor activity hence why reduced levels leads to dyskinesia.

  5. Pathophysiology • Cell death in substantia nigra (particularly pars compacta) leads to reduced dopamine secreting cells. • Dopamine acts to facilitate release of inhibition and as such in PD there is greater exertion required to initiate a movement as there is less release of inhibition.

  6. Clinical features • Resting tremor = usually unilateral before it becomes generalised. It is 4-6 Hz pill-rolling.Typically absent during activity. • Rigidity = lead pipe. Cog-wheeling occurs when lead pipe rigidity is broken up by tremor. • Bradykinesia = festinant gait (slow to start + small shuffling steps + difficult turns) Has diminished arm swing = leads to recurrent falls. You also get reduction in amplitude of repetitive movements.

  7. Other features • Progressive decline over years • Mask-like face • Impaired swallowing – drooling, choking on food • Cognitive decline = depression + dementia • Quiet voice progressing to dysarthria • Micrographia (small + spidery writing)

  8. DDx • Wilson’s • Lewy Body dementia: get visual hallucinations • CJD: Dementia + myoclonic jerking • Parkinson’s plus • Huntington’s disease • Drug-induced PD • Antipsychotics (APAT side effects: acute dystonia, parkinsonism, akathisia, tardive dyskinesia) • Lithium • Benign essential tremor • Rarely at rest, worse on movement • Family hx

  9. NICE criteria for Dx • Exclude other causes • Bradykinesia + at least 1 of: • Rigidity • 4-6Hz resting tremor • Postural instability • Supportive criteria: • Unilateral • Progressive nature • Asymmetry before bilateral • Response to L-Dopa

  10. Investigations • Typically a clinical diagnosis • Use: • Bedside: BP lying + standing, urine dip • Bloods: Genetic testing for Huntington’s or caeruloplasmin for Wilson’s • Imaging: CT/MRI • Fail to respond to L-Dopa • Can visualise structural defects • Special tests: DAT scan can differentiate between drug-induced + PD.

  11. Conservative management • Advice + explanation, consider non-physical problems (depression, poor sleep, dementia). • Limited time frame for meds so start when really needed + started by neurologist! • MDT: specialist nurses, OT, SALT, psychiatrist, GP, neurologist, dietician • Inform DVLA • REHAB

  12. Medical management • Drugs alter the natural progression – they just improve symptoms. • Levodopa • Is the most effective drug. • It crosses the BBB and enters the nigrostriatal neurones and is converted to dopamine. • Give with dopa-decarboxylase inhibitor e.g. carbidopa to inhibit peripheral metabolism. S/E = N+V, confusion, on-off phenomena, wearing off + dyskinesia, hallucination

  13. Dopamine agonists e.g. Pramipexole =good for motor sx • 1st line in younger patients • MAO-B inhibitors = selegiline = block dopamine breakdown. Good for motor sx. • COMT inhibitors = entacapone = inhibits peripheral break down. S/E = hepatotoxic, N+V, confusion. • Amantadine: can be used as monotherapy in early PD but has poor evidence base. Enhances dopamine release. • Apomorphine can reduce off periods given as s/c injection. S/E confusion + hallucinations

  14. Surgical • Deep brain stimulation • Pallidotomy involves surgical destruction of the globus pallidus to control dyskinesia.

  15. Complications • Infection • Aspiration pneumonia • Bed sores • Poor nutrition • Falls • PD dementia

  16. Prognosis • Slowly progressive • Mean duration 15 years • Variable severity • Earlier age of onset = poorer prognosis • Death usually from complications e.g. pneumonia.

  17. Parkinson’s plus syndromes • Disorders with parkinsonism + additional features + specific pathology. • Vascular dementia • Orthotic hypotension = multi-system atrophy gives insomnia, somnolence, restless legs, hallucinations. Use fludrocortisone for BP • Dementia + vertical gaze palsy= progressive supra-nuclear palsy • Kayser-Fleischer rings = Wilson’s • Apraxic gait – communicating hydrocephalus

  18. Good luck!  • Parkinson’s notes • http://www.patient.co.uk/doctor/parkinsonism-and-parkinsons-disease • Extrapyramidal exam • http://youtu.be/6PDxANv_ME8 • Gait • http://youtu.be/7SyTpEdhBLw

More Related